Invesco Biotechnology & Genome ETF
ETFYour view on PBE
Invesco Biotechnology & Genome ETF
ETFInvescoSentiment
AUM (USD)
$405.87M
Expense Ratio
0.59%
Holdings
31
Sentiment
Overview for Invesco Biotechnology & Genome ETF
- Fund Type
- ETF
- Fund Issuer
- Invesco
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- June 23, 2005
- Domicile
- US
- Fund Type
- ETF
- Fund Issuer
- Invesco
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- June 23, 2005
- Domicile
- US
- Fund Type
- ETF
- Fund Issuer
- Invesco
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- June 23, 2005
- Domicile
- US
About this fund
The Invesco Biotechnology & Genome ETF (Fund) is based on the Dynamic Biotech & Genome Intellidex Index (Index). The Fund will normally invest at least 90% of its total assets in the securities that comprise the Index. The Index is designed to provide capital appreciation by thor…
PBE Stock Price
Key Facts
EquityExpense Ratio
0.59%
AUM
$405.87M
Fund Details
Expense Ratio
0.59%
Assets Under Management
$405.87M
NAV
$93.09 USD
Holdings
31
Average Volume
20.3K
Inception Date
June 23, 2005
Asset Class
Equity
Fund Issuer
Invesco
Domicile
US
ISIN
US46137V7872
CUSIP
46137V787
NAV Currency
USD
Expense Ratio
0.59%
Assets Under Management
$405.87M
NAV
$93.09 USD
Holdings
31
Average Volume
20.3K
Inception Date
June 23, 2005
Asset Class
Equity
Fund Issuer
Invesco
Domicile
US
ISIN
US46137V7872
CUSIP
46137V787
NAV Currency
USD
Latest headlines and company announcements for this company. Press releases and market coverage, newest first.
News
this company valued side by side against its closest peers. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.